Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1984 Dec;117(3):451–461.

Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues.

C Ernst, J Thurin, B Atkinson, H Wurzel, M Herlyn, N Stromberg, C Civin, H Koprowski
PMCID: PMC1900579  PMID: 6507589

Abstract

The expression of human blood group A and B isoantigens in normal and malignant tissues from stomach, colon, and pancreas was analyzed in an immunoperoxidase assay using monoclonal antibodies specific for these isoantigens. Appropriate isoantigen expression was demonstrated in the normal epithelium from the stomach, pancreas, and proximal but not distal colon of blood group A, AB, or B patients. Half of all gastric carcinomas and of proximal colon carcinomas showed complete loss of isoantigen, whereas the adjacent mucosa in these cases continued to express appropriate isoantigen. Isoantigen expression was completely lost in only 13% of pancreatic carcinomas tested. Neither A nor B isoantigen was detected in normal epithelium from the distal colon. By contrast, 85% of carcinomas derived from this site showed reexpression of isoantigen. Inappropriate expression of A isoantigen was detected in pancreatic carcinomas (2/5) but not in gastric or colon carcinomas (0/21). Inappropriate expression of B substance was not detected in any tissue (0/38). Interestingly, differential binding of antibodies to Type 1 versus Type 2 and/or difucosyl versus monofucosyl blood group B substances was manifested by differences in intensity of staining for endothelium and red blood cells.

Full text

PDF
451

Images in this article

455Figure 2
on p.455
453Figure 1
on p.453
457Figure 3
on p.457
458Figure 4
on p.458
459Figure 5
on p.459

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson B. F., Ernst C. S., Herlyn M., Steplewski Z., Sears H. F., Koprowski H. Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res. 1982 Nov;42(11):4820–4823. [PubMed] [Google Scholar]
  2. Breimer M. E. Adaptation of mass spectrometry for the analysis of tumor antigens as applied to blood group glycolipids of a human gastric carcinoma. Cancer Res. 1980 Mar;40(3):897–908. [PubMed] [Google Scholar]
  3. Breimer M. E., Hansson G. C., Karlsson K. A., Leffler H. Glycosphingolipids and the differentiation of intestinal epithelium. Exp Cell Res. 1981 Sep;135(1):1–13. doi: 10.1016/0014-4827(81)90293-7. [DOI] [PubMed] [Google Scholar]
  4. Breimer M. E., Hansson G. C., Karlsson K. A., Leffler H., Pimlott W., Samuelsson B. E. Selected ion monitoring of glycospingolipid mixtures. Identification of several blood group type glycolipids in the small intestine of an individual rabbit. Biomed Mass Spectrom. 1979 Jun;6(6):231–241. doi: 10.1002/bms.1200060603. [DOI] [PubMed] [Google Scholar]
  5. Breimer M. E., Karlsson K. A., Samuelsson B. E. Characterization of a blood group H type pentaglycosylceramide of human pancreas based on a type 1 carbohydrate chain. J Biol Chem. 1981 Apr 25;256(8):3810–3816. [PubMed] [Google Scholar]
  6. Cooper H. S., Haesler W. E., Jr Blood group substances as tumor antigens in the distal colon. Am J Clin Pathol. 1978 Jun;69(6):594–598. doi: 10.1093/ajcp/69.6.594. [DOI] [PubMed] [Google Scholar]
  7. Dabelsteen E., Vedtofte P., Hakomori S., Young W. W., Jr Accumulation of a blood group antigen precursor in oral premalignant lesions. Cancer Res. 1983 Mar;43(3):1451–1454. [PubMed] [Google Scholar]
  8. Davidsohn I., Kovarik S., Lee C. L. A, B, and O substances in gastrointestinal carcinoma. Arch Pathol. 1966 May;81(5):381–390. [PubMed] [Google Scholar]
  9. Davidsohn I., Ni L. Y., Stejskal R. Tissue isoantigens A,B, and H in carcinoma of the stomach. Arch Pathol. 1971 Dec;92(6):456–464. [PubMed] [Google Scholar]
  10. Denk H., Tappeiner G., Davidovits A., Eckerstorfer R., Holzner J. H. Carcinoembryonic antigen and blood group substances in carcinomas of the stomach and colon. J Natl Cancer Inst. 1974 Oct;53(4):933–942. doi: 10.1093/jnci/53.4.933. [DOI] [PubMed] [Google Scholar]
  11. Ernst C., Atkinson B., Wysocka M., Blaszczyk M., Herlyn M., Sears H., Steplewski Z., Koprowski H. Monoclonal antibody localization of Lewis antigens in fixed tissue. Lab Invest. 1984 Apr;50(4):394–400. [PubMed] [Google Scholar]
  12. Falk K. E., Karlsson K. A., Samuelsson B. E. Proton nuclear magnetic resonance analysis of anomeric structure of glycosphingolipids. The globo-series (one to five sugars). Arch Biochem Biophys. 1979 Jan;192(1):164–176. doi: 10.1016/0003-9861(79)90082-1. [DOI] [PubMed] [Google Scholar]
  13. Finan P. J., Wight D. G., Lennox E. S., Sacks S. H., Bleehen N. M. Human blood group isoantigen expression on normal and malignant gastric epithelium studied with anti-A and anti-B monoclonal antibodies. J Natl Cancer Inst. 1983 Apr;70(4):679–685. [PubMed] [Google Scholar]
  14. Hakomori S. Blood group ABH and Ii antigens of human erythrocytes: chemistry, polymorphism, and their developmental change. Semin Hematol. 1981 Jan;18(1):39–62. [PubMed] [Google Scholar]
  15. Hakomori S., Kannagi R. Glycosphingolipids as tumor-associated and differentiation markers. J Natl Cancer Inst. 1983 Aug;71(2):231–251. [PubMed] [Google Scholar]
  16. Hakomori S., Nudelman E., Levery S. B., Patterson C. M. Human cancer-associated gangliosides defined by a monoclonal antibody (IB9) directed to sialosyl alpha 2 leads to 6 galactosyl residue: a preliminary note. Biochem Biophys Res Commun. 1983 Jun 29;113(3):791–798. doi: 10.1016/0006-291x(83)91069-0. [DOI] [PubMed] [Google Scholar]
  17. Hakomori S., Stellner K., Watanabe K. Four antigenic variants of blood group A glycolipid: examples of highly complex, branched chain glycolipid of animal cell membrane. Biochem Biophys Res Commun. 1972 Nov 15;49(4):1061–1068. doi: 10.1016/0006-291x(72)90320-8. [DOI] [PubMed] [Google Scholar]
  18. Hansson G. C., Karlsson K. A., Larson G., McKibbin J. M., Blaszczyk M., Herlyn M., Steplewski Z., Koprowski H. Mouse monoclonal antibodies against human cancer cell lines with specificities for blood group and related antigens. Characterization by antibody binding to glycosphingolipids in a chromatogram binding assay. J Biol Chem. 1983 Apr 10;258(7):4091–4097. [PubMed] [Google Scholar]
  19. Hattori H., Uemura K., Taketomi T. The presence of blood group A-active glycolipids in cancer tissues from blood group O patients. Biochim Biophys Acta. 1981 Dec 23;666(3):361–369. doi: 10.1016/0005-2760(81)90295-2. [DOI] [PubMed] [Google Scholar]
  20. Herlyn M., Shen J. W., Sears H. F., Civin C. I., Verrill H. L., Goldberg E. M., Koprowski H. Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants. Clin Exp Immunol. 1984 Jan;55(1):23–35. [PMC free article] [PubMed] [Google Scholar]
  21. Holmes E. H., Hakomori S. Isolation and characterization of a new fucoganglioside accumulated in precancerous rat liver and in rat hepatoma induced by N-2-acetylaminofluorene. J Biol Chem. 1982 Jul 10;257(13):7698–7703. [PubMed] [Google Scholar]
  22. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  23. Häkkinen I. A-like blood group antigen in gastric cancer cells of patients in blood groups Q or B. J Natl Cancer Inst. 1970 May;44(5):1183–1193. [PubMed] [Google Scholar]
  24. Kabat E. A. Philip Levine Award Lecture. Contributions of quantitative immunochemistry to knowledge of blood group A, B, H, Le, I and i antigens. Am J Clin Pathol. 1982 Sep;78(3):281–292. doi: 10.1093/ajcp/78.3.281. [DOI] [PubMed] [Google Scholar]
  25. Kannagi R., Levine P., Watanabe K., Hakomori S. Recent studies of glycolipid and glycoprotein profiles and characterization of the major glycolipid antigen in gastric cancer of a patient of blood group genotype pp (Tja-) first studied in 1951. Cancer Res. 1982 Dec;42(12):5249–5254. [PubMed] [Google Scholar]
  26. Kapadia A., Feizi T., Jewell D., Keeling J., Slavin G. Immunocytochemical studies of blood group A, H, I, and i antigens in gastric mucosae of infants with normal gastric histology and of patients with gastric carcinoma and chronic benign peptic ulceration. J Clin Pathol. 1981 Mar;34(3):320–337. doi: 10.1136/jcp.34.3.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Karlsson K. A., Larson G. Molecular characterization of cell surface antigens of fetal tissue. Detailed analysis of glycosphingolipids of meconium of a human O Le(a--b+) secretor. J Biol Chem. 1981 Apr 10;256(7):3512–3524. [PubMed] [Google Scholar]
  28. Karlsson K. A., Larson G. Potential use of glycosphingolipids of human meconium for blood group chemotyping of single individuals. FEBS Lett. 1981 Jun 1;128(1):71–74. doi: 10.1016/0014-5793(81)81082-4. [DOI] [PubMed] [Google Scholar]
  29. Kościelak J., Plasek A., Górniak H., Gardas A., Gregor A. Structures of fucose-containing glycolipids with H and B blood-group activity and of sialic acid and glucosamine-containing glycolipid of human-erythrocyte membrane. Eur J Biochem. 1973 Aug 17;37(2):214–225. doi: 10.1111/j.1432-1033.1973.tb02978.x. [DOI] [PubMed] [Google Scholar]
  30. LEVINE P., BOBBITT O. B., WALLER R. K., KUHMICHEL A. Isoimmunization by a new blood factor in tumor cells. Proc Soc Exp Biol Med. 1951 Jul;77(3):403–405. doi: 10.3181/00379727-77-18794. [DOI] [PubMed] [Google Scholar]
  31. Limas C., Lange P. Altered reactivity for A, B, H antigens in transitional cell carcinomas of the urinary bladder. A study of the mechanisms involved. Cancer. 1980 Sep 15;46(6):1366–1373. doi: 10.1002/1097-0142(19800915)46:6<1366::aid-cncr2820460613>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  32. Limas C., Lange P., Fraley E. E., Vessella R. L. A, B, H antigens in transitional cell tumors of the urinary bladder: correlation with the clinical course. Cancer. 1979 Dec;44(6):2099–2107. doi: 10.1002/1097-0142(197912)44:6<2099::aid-cncr2820440621>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  33. Magnani J. L., Nilsson B., Brockhaus M., Zopf D., Steplewski Z., Koprowski H., Ginsburg V. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem. 1982 Dec 10;257(23):14365–14369. [PubMed] [Google Scholar]
  34. McKibbin J. M., Smith E. L., Månsson J. E., Li Y. T. Characterization of dog small intestinal fucolipids with human blood group A activity. Differences in dog and human A-active fucolipids. Biochemistry. 1977 Mar 22;16(6):1223–1228. doi: 10.1021/bi00625a030. [DOI] [PubMed] [Google Scholar]
  35. Oriol R., Cooper J. E., Davies D. R., Keeling P. W. ABH antigens in vascular endothelium and some epithelial tissues of baboons. Lab Invest. 1984 May;50(5):514–518. [PubMed] [Google Scholar]
  36. REGE W. P., PAINTER T. J., WATKINS W. M., MORGAN W. T. ISOLATION OF SEROLOGICALLY ACTIVE FUCOSE-CONTAINING OLIGOSACCHARIDES FROM HUMAN BLOOD-GROUP H SUBSTANCE. Nature. 1964 Jul 25;203:360–363. doi: 10.1038/203360a0. [DOI] [PubMed] [Google Scholar]
  37. SZULMAN A. E. THE HISTOLOGICAL DISTRIBUTION OF THE BLOOD GROUP SUBSTANCES IN MAN AS DISCLOSED BY IMMUNOFLUORESCENCE. III. THE A, B, AND H ANTIGENS IN EMBRYOS AND FETUSES FROM 18 MM IN LENGTH. J Exp Med. 1964 Apr 1;119:503–516. doi: 10.1084/jem.119.4.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. SZULMAN A. E. The histological distribution of blood group substances A and B in man. J Exp Med. 1960 Jun 1;111:785–800. doi: 10.1084/jem.111.6.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Siddiqui B., Whitehead J. S., Kim Y. S. Glycosphingolipids in human colonic adenocarcinoma. J Biol Chem. 1978 Apr 10;253(7):2168–2175. [PubMed] [Google Scholar]
  40. Smith E. L., McKibbin J. M., Karlsson K. A., Pascher I., Samuelsson B. E. Characterization by mass spectrometry of blood group A active glycolipids from human and dog small intestins. Biochemistry. 1975 May 20;14(10):2120–2124. doi: 10.1021/bi00681a012. [DOI] [PubMed] [Google Scholar]
  41. Smith E. L., Mckibbin J. M., Breimer M. E., Karlsson K. A., Pascher I., Samuelson B. E. Identification of a novel hepraglycosylceramide with two fucose residues and a terminal hexosamine. Biochim Biophys Acta. 1975 Jul 22;398(1):84–91. doi: 10.1016/0005-2760(75)90171-x. [DOI] [PubMed] [Google Scholar]
  42. Stellner K., Watanabe K., Hakomori S. Isolation and characterization of glycosphingolipids with blood group H specificity from membranes of human erythrocytes. Biochemistry. 1973 Feb;12(4):656–661. doi: 10.1021/bi00728a014. [DOI] [PubMed] [Google Scholar]
  43. Sung S. S., Esselman W. J., Sweeley C. C. Structure of a pentahexosylceramide (Forssman hapten) from canine intestine and kidney. J Biol Chem. 1973 Sep 25;248(18):6528–6533. [PubMed] [Google Scholar]
  44. Warren L., Fuhrer J. P., Buck C. A. Surface glycoproteins of normal and transformed cells: a difference determined by sialic acid and a growth-dependent sialyl transferase. Proc Natl Acad Sci U S A. 1972 Jul;69(7):1838–1842. doi: 10.1073/pnas.69.7.1838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Watkins E., Jr, Ogata Y., Anderson L. L., Watkins E., 3rd, Waters M. F. Activation of host lymphocytes cultured with cancer cells treated with neuraminidase. Nat New Biol. 1971 May 19;231(20):83–85. doi: 10.1038/newbio231083a0. [DOI] [PubMed] [Google Scholar]
  46. Wherrett J. R., Hakomori S. I. Characterization of a blood group B glycolipid, accumulating in the pancreas of a patient with Fabry's disease. J Biol Chem. 1973 May 10;248(9):3046–3051. [PubMed] [Google Scholar]
  47. Wiley E. L., Mendelsohn G., Eggleston J. C. Distribution of carcinoembryonic antigens and blood group substances in adenocarcinoma of the colon. Lab Invest. 1981 Jun;44(6):507–513. [PubMed] [Google Scholar]
  48. Wiley E. L., Murphy P., Mendelsohn G., Eggleston J. C. Distribution of blood group substances in normal human colon. Use of the unlabeled antibody (PAP) immunoperoxidase technic to identify A and B blood group substances. Am J Clin Pathol. 1981 Dec;76(6):806–809. doi: 10.1093/ajcp/76.6.806. [DOI] [PubMed] [Google Scholar]
  49. Yokota M., Warner G. A., Hakomori S. Blood group A-like glycolipid and a novel Forssman antigen in the hepatocarcinoma of a blood group O individual. Cancer Res. 1981 Oct;41(10):4185–4190. [PubMed] [Google Scholar]
  50. van Beek W. P., Smets L. A., Emmelot P. Increased sialic acid density in surface glycoprotein of transformed and malignant cells--a general phenomenon? Cancer Res. 1973 Nov;33(11):2913–2922. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES